These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36939042)

  • 1. Microcosting diagnostic genomic sequencing: A systematic review.
    Santos Gonzalez F; Mordaunt D; Stark Z; Dalziel K; Christodoulou J; Goranitis I
    Genet Med; 2023 Jun; 25(6):100829. PubMed ID: 36939042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of proband and trio exome and genome analysis in rare disease: A micro-costing study.
    Mordaunt DA; Gonzalez FS; Lunke S; Eggers S; Sadedin S; Chong B; Dalziel K; Stark Z; Goranitis I
    Genet Med; 2024 Apr; 26(4):101058. PubMed ID: 38164890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.
    Schwarze K; Buchanan J; Fermont JM; Dreau H; Tilley MW; Taylor JM; Antoniou P; Knight SJL; Camps C; Pentony MM; Kvikstad EM; Harris S; Popitsch N; Pagnamenta AT; Schuh A; Taylor JC; Wordsworth S
    Genet Med; 2020 Jan; 22(1):85-94. PubMed ID: 31358947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia.
    Mordaunt DA; Stark Z; Santos Gonzalez F; Dalziel K; Goranitis I
    BMJ Open; 2023 Nov; 13(11):e069441. PubMed ID: 38030253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
    Schwarze K; Buchanan J; Taylor JC; Wordsworth S
    Genet Med; 2018 Oct; 20(10):1122-1130. PubMed ID: 29446766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the costs of genomic sequencing in cancer control.
    Gordon LG; White NM; Elliott TM; Nones K; Beckhouse AG; Rodriguez-Acevedo AJ; Webb PM; Lee XJ; Graves N; Schofield DJ
    BMC Health Serv Res; 2020 Jun; 20(1):492. PubMed ID: 32493298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Checklist for the Conduct, Reporting, and Appraisal of Microcosting Studies in Health Care: Protocol Development.
    Ruger JP; Reiff M
    JMIR Res Protoc; 2016 Oct; 5(4):e195. PubMed ID: 27707687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
    Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
    Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice.
    Jani M; Gavan S; Chinoy H; Dixon WG; Harrison B; Moran A; Barton A; Payne K
    Rheumatology (Oxford); 2016 Dec; 55(12):2131-2137. PubMed ID: 27576368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation.
    McKenna C; Wade R; Faria R; Yang H; Stirk L; Gummerson N; Sculpher M; Woolacott N
    Health Technol Assess; 2012; 16(14):1-188. PubMed ID: 22449757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
    Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
    Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.
    Stark Z; Schofield D; Martyn M; Rynehart L; Shrestha R; Alam K; Lunke S; Tan TY; Gaff CL; White SM
    Genet Med; 2019 Jan; 21(1):173-180. PubMed ID: 29765138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions.
    Shrestha RK; Sansom SL; Farnham PG
    J Public Health Manag Pract; 2012; 18(3):259-67. PubMed ID: 22473119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.
    Tappenden P; Campbell F; Rawdin A; Wong R; Kalita N
    Health Technol Assess; 2012; 16(20):1-72. PubMed ID: 22490205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis in implementation studies of evidence-based practices for mental health and substance use disorders: a systematic review.
    Bowser DM; Henry BF; McCollister KE
    Implement Sci; 2021 Mar; 16(1):26. PubMed ID: 33706780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.
    Hayeems RZ; Bernier F; Boycott KM; Hartley T; Michaels-Igbokwe C; Marshall DA
    BMJ Open; 2022 Oct; 12(10):e061468. PubMed ID: 36216418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.
    Czoski-Murray C; Lloyd Jones M; McCabe C; Claxton K; Oluboyede Y; Roberts J; Nicholl JP; Rees A; Reilly CS; Young D; Fleming T
    Health Technol Assess; 2012 Dec; 16(50):i-xvi, 1-159. PubMed ID: 23302507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.